The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis

[1]  S. Imafuku,et al.  Clinical characteristics of Japanese pustular psoriasis: A multicenter observational study , 2021, The Journal of dermatology.

[2]  A. Morita,et al.  Clinical characteristics and health‐care resource utilization in patients with generalized pustular psoriasis using real‐world evidence from the Japanese Medical Data Center database , 2021, The Journal of dermatology.

[3]  A. Morita,et al.  Patient characteristics and burden of disease in Japanese patients with generalized pustular psoriasis: Results from the Medical Data Vision claims database , 2021, The Journal of dermatology.

[4]  H. Yasunaga,et al.  Treatments and outcomes of generalized pustular psoriasis: a cohort of 1516 patients in a nationwide inpatient database in Japan. , 2021, Journal of the American Academy of Dermatology.

[5]  Qing Luo,et al.  An update on genetic basis of generalized pustular psoriasis (Review) , 2021, International journal of molecular medicine.

[6]  W. Valdecantos,et al.  Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United States , 2021, Current medical research and opinion.

[7]  J. Crowley,et al.  A brief guide to pustular psoriasis for primary care providers , 2020, Postgraduate medicine.

[8]  M. Mockenhaupt,et al.  Loss-of-Function Myeloperoxidase Mutations Are Associated with Increased Neutrophil Counts and Pustular Skin Disease , 2020, American journal of human genetics.

[9]  D. Esser,et al.  The clinical, humanistic, and economic burden of generalized pustular psoriasis: a structured review , 2020, Expert review of clinical immunology.

[10]  A. Ekici,et al.  Rare loss-of-function mutation in SERPINA3 in generalized pustular psoriasis. , 2020, The Journal of investigative dermatology.

[11]  M. Akiyama,et al.  Generalized Pustular Psoriasis: Clinical Management and Update on Autoinflammatory Aspects , 2019, American Journal of Clinical Dermatology.

[12]  Masaru Tanaka,et al.  Case of generalized pustular psoriasis with coexisting mutations in IL36RN and CARD14 , 2019, The Journal of dermatology.

[13]  A. Olry,et al.  Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database , 2019, European Journal of Human Genetics.

[14]  M. Lebwohl,et al.  An update on generalized pustular psoriasis , 2019, Expert review of clinical immunology.

[15]  Kristen M Beck,et al.  Diagnosis and screening of patients with generalized pustular psoriasis , 2019, Psoriasis.

[16]  Adriana Rendon,et al.  Psoriasis Pathogenesis and Treatment , 2019, International journal of molecular sciences.

[17]  Kaspar Torz,et al.  Clinical and genetic differences between pustular psoriasis subtypes , 2018, The Journal of allergy and clinical immunology.

[18]  M. Akiyama,et al.  Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP , 2018, The Journal of dermatology.

[19]  Qianyi Yang,et al.  Genetic polymorphism of IL36RN in Han patients with generalized pustular psoriasis in Sichuan region of China , 2018, Medicine.

[20]  A. Navarini,et al.  Generalized pustular psoriasis – a model disease for specific targeted immunotherapy, systematic review , 2018, Experimental dermatology.

[21]  S. Jo,et al.  Prevalence of Psoriasis in Korea: A Population-Based Epidemiological Study Using the Korean National Health Insurance Database , 2017, Annals of dermatology.

[22]  L. Naldi,et al.  European consensus statement on phenotypes of pustular psoriasis , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[23]  D. Kivelevitch,et al.  Pustular psoriasis: pathophysiology and current treatment perspectives , 2016, Psoriasis.

[24]  Daisuke Koide,et al.  Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database , 2015, BMJ Open.

[25]  Hong Liu,et al.  Mutation analysis of the IL36RN gene in Chinese patients with generalized pustular psoriasis with/without psoriasis vulgaris. , 2014, Journal of dermatological science.

[26]  N. Lai,et al.  Clinical profile, morbidity, and outcome of adult‐onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia , 2014, International journal of dermatology.

[27]  M. Akiyama,et al.  CARD14 c.526G>C (p.Asp176His) is a significant risk factor for generalized pustular psoriasis with psoriasis vulgaris in the Japanese cohort. , 2014, The Journal of investigative dermatology.

[28]  Fernanda Mendes Araújo,et al.  Pustular psoriasis of pregnancy (Impetigo herpetiformis) - Case report* , 2013, Anais brasileiros de dermatologia.

[29]  E. Cowen,et al.  Autoinflammatory pustular neutrophilic diseases. , 2013, Dermatologic clinics.

[30]  M. Simpson,et al.  Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. , 2011, American journal of human genetics.

[31]  A. Smahi,et al.  Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. , 2011, The New England journal of medicine.

[32]  M. Black,et al.  Effect of Pregnancy on Other Skin Disorders , 2008 .

[33]  J. Nicolas,et al.  Generalized pustular psoriasis (Zumbusch): a French epidemiological survey. , 2006, European journal of dermatology : EJD.

[34]  M. Rybojad,et al.  High frequency of cholestasis in generalized pustular psoriasis: Evidence for neutrophilic involvement of the biliary tract , 2004, Hepatology.

[35]  T. Tezuka,et al.  Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity , 2003, Archives of Dermatological Research.

[36]  S. Imamura,et al.  Generalized pustular psoriasis in Japan: two distinct groups formed by differences in symptoms and genetic background. , 1996, Acta dermato-venereologica.

[37]  S. Muller,et al.  Generalized pustular psoriasis. A review of 63 cases. , 1991, Archives of dermatology.